TORONTO, Jan. 23, 2020 /CNW/ - Mimi's Rock Corp.
(TSXV:MIMI) and Avivagen Inc. (TSXV:VIV) (collectively "the
Companies") are pleased to announce the Dr Tobias Dog Chews
containing the proprietary Avivagen
OxC-BetaTM additive are now available in
the United States on Amazon and
Drtobias.com.
"We've been working closely with the Avivagen team to launch the
first Dr Tobias branded product into the companion pet market in
the United States. With an
ever-expanding companion pet market, we believe that our existing
Dr Tobias customers will embrace the opportunity to provide the
same high standards in supplements and vitamins to their dogs,"
said Dave Kohler, CEO of Mimi's Rock
Corp.
"We're very excited to bring our high quality supplement for
companion animals to this important and growing $10 billion per year market," says Kym Anthony, Chief Executive
Officer, Avivagen Inc. "We believe the combination of
Avivagen's OxC-betaTM technology with Mimi's Rock's
expertise in online sales and customer service is a win-win
scenario for both enterprises, and look forward to building upon
this partnership."
About Mimi's Rock Corp.
Mimi's Rock Corp. is an online dietary supplement and wellness
company which operates the Dr Tobias, All Natural Advice and
Maritime Naturals brands. The Dr Tobias brand features over 30
products including the top-selling Colon
14 Day Cleanse and the #1 best-selling Omega 3 Fish Oil on
Amazon.com. The Omega 3 Fish Oil is also the 4th largest
subscribe & save product on Amazon.com. Mimi's Rock Corp. has
rapid growth plans as it continues to expand into global markets.
For more information, visit www.mimisrock.com.
About Avivagen Inc.
Avivagen is a life sciences corporation focused on developing
and commercializing products for livestock, companion animal and
human applications that, by safely supporting immune function,
promote general health and performance. It's a
public corporation traded on the TSX Venture Exchange under
the symbol VIV and is headquartered in Ottawa, Canada, based in partnership
facilities of the National Research
Council of Canada and
Charlottetown, Prince Edward
Island. For more information, visit www.avivagen.com. The
contents of the website are expressly not incorporated by reference
in this press release.
Forward-Looking Information
This news release includes "forward-looking information," as
such term is defined in applicable securities laws. Forward-looking
information includes, without limitation, discussion of Bloom
Burton and its conference, The Companies business and business
results, goals or outlook, risks associated with financial results
and stability, development projects such as those referenced
herein, sales to foreign jurisdictions, engineering and
construction, production (including control over costs, quality,
quantity and timeliness of delivery), foreign currency and exchange
rates, maintaining adequate working capital and raising further
capital on acceptable terms or at all, and other similar statements
concerning anticipated future events, conditions or results that
are not historical facts. These statements reflect management's
current estimates, beliefs, intentions and expectations; they are
not guarantees of future performance. The Companies caution that
all forward looking information is inherently uncertain and that
actual performance may be affected by a number of material factors,
many of which are beyond the Companies control. Accordingly, actual
future events, conditions and results may differ materially from
the estimates, beliefs, intentions and expectations expressed or
implied in the forward-looking information. All statements are made
as of the date of this news release and represent the Companies
judgement as of the date of this new release, and the Companies are
under no obligation to update or alter any forward-looking
information.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this news release.
Please visit www.mimisrock.com or www.sedar.com for recent
Mimi's Rock Corp. filings. Please visit www.avivagen.com or
www.sedar.com for recent Avivagen Inc. filings.
Copyright © 2020 Avivagen Inc. OxC-beta™ is a trademark of
Avivagen Inc.
SOURCE Mimi's Rock Corp.
